Cite
HARVARD Citation
Beale, D. et al. (2021). ONO‐7684 a novel oral FXIa inhibitor: Safety, tolerability, pharmacokinetics and pharmacodynamics in a first‐in‐human study. British journal of clinical pharmacology. 87 (8), pp. 3177-3189. [Online].